Welcome to our dedicated page for Waters SEC filings (Ticker: WAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Waters Corporation filings document operating results, proxy governance, capital-structure changes, material agreements, and corporate events for a NYSE-listed life sciences and diagnostics company. Recent 8-K reports include quarterly and annual results, exhibits furnished with earnings releases, and disclosure tied to the completed combination with BD’s Biosciences and Diagnostic Solutions business.
The company’s SEC record also covers senior unsecured notes issued by Augusta SpinCo Corporation and guaranteed by Waters and certain subsidiaries, pro forma and combined financial information for the acquired business, and definitive proxy materials addressing board oversight, shareholder voting matters, executive compensation, and governance practices.
Waters Corp senior vice president and chief financial officer Amol Chaubal reported an insider transaction related to equity compensation. On this Form 4, 709 shares of common stock were withheld by the company on March 2, 2026 to satisfy tax obligations tied to the vesting of previously reported performance stock units, at a price of $307.23 per share. This was a tax-withholding disposition rather than an open-market sale. After this withholding, Chaubal directly holds 7,796.393 shares of Waters common stock.
Waters Corporation senior vice president Jianqing Bennett reported a tax-related share disposition. On this Form 4, 410 shares of common stock were withheld by the company at a price of $307.23 per share to satisfy tax withholding obligations tied to vesting of previously reported performance stock units. After this withholding, Bennett directly owns 6,834 shares of Waters common stock.
Carpio Robert L III reported acquisition or exercise transactions in this Form 4 filing.
Waters Corp senior vice president Robert L. Carpio III received new equity awards, not open-market purchases or sales. He was granted 4,884 stock options and 997 restricted stock units as of February 25, 2026. The options and RSUs both vest in four equal annual installments starting on February 25, 2027, contingent on his continued service. Following the RSU grant, his directly held common stock position is 3,615 shares.
Waters Corporation SVP Jianqing Bennett reported equity awards that increase his direct ownership. He received stock options for 4,826 shares at an exercise price of $0.0000 per share and a grant of 986 shares of common stock, both described as grant or award acquisitions.
The common stock grant represents restricted stock units that convert into one share of common stock each upon vesting and settlement. Both the RSUs and the stock options will vest in four equal annual installments, with the first installment scheduled to vest on February 25, 2027, contingent on his continued service with the company.
Waters Corporation SVP & Chief Financial Officer Amol Chaubal received new equity awards. He was granted a stock option covering 7,125 shares and an award of 1,455 shares of common stock as a grant or other acquisition at no cash cost per share.
The 1,455-share grant represents restricted stock units that vest in four equal annual installments starting on February 25, 2027, and convert into common stock on a one-to-one basis at settlement. The 7,125-share stock option also vests in four equal annual installments beginning on February 25, 2027, contingent on his continued service.
Waters Corporation President and CEO Udit Batra reported equity awards that increase his direct holdings through compensation grants, not open-market trades. He received a stock option covering 25,283 shares at a grant price of $0.00 and a grant of 5,165 shares of common stock.
The 5,165-share grant represents restricted stock units that convert one-for-one into common stock and vest in four equal annual installments starting on February 25, 2027, subject to continued service. The 25,283-share stock option also vests in four equal annual installments beginning on February 25, 2027, and becomes exercisable on the same schedule.
Waters Corporation director Mark Vergnano reported equity awards rather than open-market trades. On February 25, 2026, he received a grant of stock options for 57 shares at an exercise price of $0.00 per share and an award of 23 shares of common stock, both as acquisitions.
The 23 common shares are restricted stock that remain subject to restrictions until February 9, 2027, when 100% of these restrictions lapse. All 57 shares underlying the stock option will vest and become exercisable on February 9, 2027. After these awards, he directly owns 4,540 shares of Waters common stock.
Waters Corp director Christopher A. Kuebler reported equity awards that increase his direct holdings. On February 25, 2026, he received a stock option for 57 shares at an exercise price of $0.00 per share and a grant of 23 shares of common stock at $0.00 per share.
The 23 common shares are subject to restrictions that lapse for all shares on February 9, 2027, and all 57 option shares vest and become exercisable on the same date. Following the stock grant, Kuebler directly owns 17,808 shares of Waters common stock.
Waters Corporation director Heather Knight reported awards of both stock options and restricted common shares. She received stock options for 57 shares at an exercise price of $0.0000 per share and a grant of 23 common shares, all as awards rather than open-market purchases.
The 23 common shares are subject to restrictions that lapse for all of the shares on February 9, 2027. All 57 option shares will vest and become exercisable on February 9, 2027. After these grants, her directly owned common shares total 1,149.070.
Waters Corporation director Jiang Wei reported receiving new equity awards. He acquired 23 shares of common stock at no cost, which are subject to restrictions that lapse in full on February 9, 2027. He was also granted a stock option for 57 shares that becomes fully exercisable on February 9, 2027. Both positions are held as direct ownership.